Patents by Inventor Betsy J. Barnes

Betsy J. Barnes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CELL PENETRATING PEPTIDES THAT INHIBIT IRF5 NUCLEAR LOCALIZATION
    Publication number: 20240043482
    Abstract: The invention provides inhibitors of interferon regulatory factor 5 FIG. 5 (IRF5) nuclear localization and methods of using the inhibitors to treat autoimmune diseases such as systemic lupus erythematosus (SLE).
    Type: Application
    Filed: July 12, 2023
    Publication date: February 8, 2024
    Applicant: Rutgers, The State University of New Jersey
    Inventor: Betsy J. Barnes
  • Cell penetrating peptides that inhibit IRF5 nuclear localization
    Patent number: 11746133
    Abstract: Inhibitors of interferon regulatory factor 5 (IRF5) nuclear localization and methods of using the inhibitors to treat autoimmune diseases such as systemic lupus erythematosus (SLE) are described.
    Type: Grant
    Filed: September 13, 2021
    Date of Patent: September 5, 2023
    Assignee: Rutgers, The State University of New Jersey
    Inventor: Betsy J. Barnes
  • INTERFERON REGULATORY FACTOR 5 INHIBITORS AND USES THEREOF
    Publication number: 20220220168
    Abstract: Polypeptides comprising a cell penetrating amino acid sequence and an interferon regulatory factor 5 (IRF5) targeting amino acid sequence are disclosed, where the IRF5 targeting amino acid sequence is one or more of RHATRHG (SEQ ID NO:1), KSRDFRL (SEQ ID NO:2) and GPRDMPP (SEQ ID NO:3), as well as methods of using these polypeptides to treat diseases, such as autoimmune and inflammatory diseases.
    Type: Application
    Filed: May 4, 2020
    Publication date: July 14, 2022
    Applicant: THE FEINSTEIN INSTITUES FOR MEDICAL RESEARCH
    Inventors: Betsy J. Barnes, Shan Sun
  • CELL PENETRATING PEPTIDES THAT INHIBIT IRF5 NUCLEAR LOCALIZATION
    Publication number: 20210403520
    Abstract: Inhibitors of interferon regulatory factor 5 (IRF5) nuclear localization and methods of using the inhibitors to treat autoimmune diseases such as systemic lupus erythematosus (SLE) are described.
    Type: Application
    Filed: September 13, 2021
    Publication date: December 30, 2021
    Applicant: Rutgers, The State University of New Jersey
    Inventor: Betsy J. Barnes
  • Cell penetrating peptides that inhibit IRF5 nuclear localization
    Patent number: 11130790
    Abstract: Inhibitors of interferon regulatory factor 5 (IRF5) nuclear localization and methods of using the inhibitors to treat autoimmune diseases such as systemic lupus erythematosus (SLE) are described.
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: September 28, 2021
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventor: Betsy J. Barnes
  • CELL PENETRATING PEPTIDES THAT INHIBIT IRF5 NUCLEAR LOCALIZATION
    Publication number: 20200071370
    Abstract: The invention provides inhibitors of interferon regulatory factor 5 (IRF5) nuclear localization and methods of using the inhibitors to treat autoimmune diseases such as systemic lupus erythematosus (SLE).
    Type: Application
    Filed: September 13, 2019
    Publication date: March 5, 2020
    Applicant: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventor: Betsy J. Barnes
  • Method for Automated Autoantibody Detection and Identification
    Publication number: 20130052662
    Abstract: The present invention is a kit and method for detecting and identifying autoantibodies. The invention employs the use of indirect immunofluorescence, imaging flow cytometry and pattern recognition software to automatically identify autoantibodies associated with autoimmune disorders.
    Type: Application
    Filed: August 23, 2012
    Publication date: February 28, 2013
    Applicant: University of Medicine and Dentistry of New Jersey
    Inventors: Betsy J. Barnes, Di Feng, Rivka C. Stone